Trials / Completed
CompletedNCT04918134
Investigation on Diagnosis and Treatment of Helicobacter Pylori Infection by Gastroenterologists in Shandong Province
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (actual)
- Sponsor
- Shandong University · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- —
Summary
Helicobacter pylori can lead to a variety of digestive system diseases.The eradication of Helicobacter pylori plays an importment role for the treatment of gastrointestinal ulcer and prevention of gastric cancer .Compared with other countries and regions in the world, the infection rate of Helicobacter pylori in China can reach more than 50%. The non-standard diagnosis and treatment of Helicobacter pylori greatly reduces its eradication rate and increases its drug resistance.Therefore, it is very important to strengthen the standardization of diagnosis and treatment to improve the eradication rate. The purpose of this study is to investigate the diagnosis and treatment status of Helicobacter pylori among gastroenterologists in general hospitals in Shandong Province.It can help us to understand the actual situation of diagnosis and treatment of Helicobacter pylori in hospitals at all levels, and to provide targeted diagnosis and treatment training for doctors.
Conditions
Timeline
- Start date
- 2021-07-10
- Primary completion
- 2021-08-20
- Completion
- 2021-10-07
- First posted
- 2021-06-08
- Last updated
- 2021-10-19
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04918134. Inclusion in this directory is not an endorsement.